{"transactions":[{"id":3110442,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T20:43:39.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 11, 2021 and (2) the date of the Issuer's 2021 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.47,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120036637/doc4.xml","form_type":"4"}},{"id":3499236,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T21:55:58.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":4430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 4, 2019. Price not applicable."}],"balance_after":25590,"source":{"system":"sec-edgar","filing":"0001567619-19-012967","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919012967/doc1.xml","form_type":"4"}},{"id":3520656,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T23:35:30.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the option will vest upon the earlier of (i) May 17, 2020 and (ii) the date of the Issuer's 2020 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":15.22,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-027160","document":"tv521926_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419027160/tv521926_4.xml","form_type":"4"}},{"id":3829750,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-08-30T17:55:38.000Z","date":"2018-08-28","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001567619-18-001925","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001925/doc1.xml","form_type":"4"}},{"id":3829749,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-30T17:55:38.000Z","date":"2018-08-28","kind":"sale","acquired":false,"shares":200,"price":99.12,"value":19824.0,"ownership":{"direct":true},"balance_after":21160,"source":{"system":"sec-edgar","filing":"0001567619-18-001925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001925/doc1.xml","form_type":"4"}},{"id":3829748,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-30T17:55:38.000Z","date":"2018-08-28","kind":"sale","acquired":false,"shares":7300,"price":99.11,"value":723503.0,"ownership":{"direct":true},"balance_after":21360,"source":{"system":"sec-edgar","filing":"0001567619-18-001925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001925/doc1.xml","form_type":"4"}},{"id":3829747,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-30T17:55:38.000Z","date":"2018-08-28","kind":"exercise","acquired":true,"shares":7500,"price":14.39,"value":107925.0,"ownership":{"direct":true},"balance_after":28660,"source":{"system":"sec-edgar","filing":"0001567619-18-001925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001925/doc1.xml","form_type":"4"}},{"id":3836270,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-22T23:06:59.000Z","date":"2018-08-21","kind":"sale","acquired":false,"shares":4200,"price":100.087,"value":420365.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $100.07\n to $100.11.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":21160,"source":{"system":"sec-edgar","filing":"0001567619-18-001677","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001677/doc1.xml","form_type":"4"}},{"id":3902158,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T00:48:08.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 5, 2018. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 5,000 shares inadvertently included in prior reports based on a reconciliation with the Company's records."}],"balance_after":25360,"source":{"system":"sec-edgar","filing":"0001140361-18-027793","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118027793/doc1.xml","form_type":"4"}},{"id":3910591,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-01T21:46:19.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the option will vest upon the earlier of (i) May 30, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":42.09,"expiration_date":"2028-05-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001144204-18-032469","document":"tv495554_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418032469/tv495554_4.xml","form_type":"4"}},{"id":4288683,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy) Common Stock","published_at":"2017-06-08T22:27:00.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":4910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests in full on June 6, 2018."}],"balance_after":4910,"derivative":{"exercise_price":89.6,"exercise_date":"2018-06-06","expiration_date":"2027-06-05","underlying":"Common Stock","underlying_shares":4910},"source":{"system":"sec-edgar","filing":"0001140361-17-024508","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024508/doc1.xml","form_type":"4"}},{"id":4288682,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:27:00.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 6, 2017.  Price not applicable."}],"balance_after":26060,"source":{"system":"sec-edgar","filing":"0001140361-17-024508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024508/doc1.xml","form_type":"4"}},{"id":4292806,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":148454,"kind":"person","name":"LEWIS ALAN","position":1,"cik":"0001207604","reported_name":"LEWIS ALAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T20:31:00.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest upon the earlier of (i) June 1, 2018 and (ii) the date of the Issuer's 2018 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":25.96,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001144204-17-031030","document":"v468316_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420417031030/v468316_4.xml","form_type":"4"}}]}